Skip to content

HASTA study - Healthy Aging starts with a healthy STArt;Remote electrophysiological cardiotocography (eCTG), evaluation of feasibility in (a selected group of) complicated pregnancies from 32 until 37 weeks gestational age in a Home@Hospital setting: a prospective cohort study

HASTA study - Healthy Aging starts with a healthy STArt; Remote electrophysiological cardiotocography (eCTG), evaluation of feasibility in (a selected group of) complicated pregnancies from 32 until 37 weeks gestational age in a Home@Hospital setting: a prospective cohort study - HASTA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57084
Enrollment
60
Registered
2024-11-05
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-eclampsia (PE) Pregnancy complications: fetal growth restriction (FGR) preterm prelabor rupture of membranes (PPROM)

Interventions

Remote eCTG monitoring (using Nemo Remote®), daily in a Home@Hospital setting for 30-90 minutes, or at least twice weekly at the out-patient clinic. Monitoring duration depends on signal quality and

Sponsors

Máxima MC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Minimum age of 18 years old • Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days • Singleton pregnancy • Any indication for fetal monitoring at least twice per week (e.g.): PE, FGR, PPROM • Absence of exclusion criteria > 24 hours after admission. • Oral and written informed consent

Exclusion criteria

Exclusion criteria: • An indication for intravenous medication • Blood pressure >160/110mmHg • Absent-/or reversed flow umbilical artery Doppler • HELLP • Obstetric intervention expected

Design outcomes

Primary

MeasureTime frame
The percentage of successful eCTG measurements in a Home@Hospital setting. This will be defined as the necessity to switch to conventional CTG based on the amount of signal loss.

Secondary

MeasureTime frame
Automated interpretation of eCTG monitoring, maternal and perinatal outcomes, patients- and healtcare givers satisfaction and costs. Additional outcome: Feasibility of synchronized multimodal acquisitions of maternal and fetal measurements.

Countries

Netherlands

Contacts

Public ContactS van Weelden

Máxima MC

s.vanweelden@mmc.nl040-8888384

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 5, 2026